Introduction
If you work with peptides in any capacity, research, compounding, supply, or clinical development, you've likely noticed that the testing environment is changing fast. Different research and pharmacy projects require different testing panels. This guide explains the questions each panel can answer.
Which Tests Are Most Requested?
HPLC Purity Testing
Researchers and pharmacies need to confirm that the peptide they purchased actually meets purity specifications. Our HPLC purity testing guide covers what this test reveals.
Key trend: More clients are requesting gradient method optimization for complex peptides like tirzepatide, which has a lipidated fatty acid chain that requires specialized HPLC conditions.
Mass Spectrometry Identity Confirmation
Identity confirmation compares observed mass with the expected compound in the submitted sample.
For compounding pharmacies, identity confirmation isn't optional, it's a regulatory requirement for incoming API verification.
Contaminant Screening
Heavy metal and residual solvent testing can be selected to address:
- FDA emphasis on contaminant testing for compounded injectables
- Researcher awareness that metal contaminants can confound cell culture results
- New clients from the pharmaceutical quality space entering the research peptide market
Quantity/Net Content Testing
Net content testing is an emerging category. Pharmacies and researchers want to know: does this 5 mg vial actually contain 5 mg? Agree on the assay and acceptance criteria before comparing measured content with a label claim.
Client Segments Driving Demand
Compounding Pharmacies: The Fastest-Growing Segment
Pharmacies should define a quality program according to their applicable requirements. Considerations include:
- FDA enforcement actions requiring quality documentation
- State pharmacy board audits requesting third-party COAs
- Patient safety concerns driving voluntary testing programs
These clients typically order comprehensive panels: purity + identity + endotoxin + quantity.
Research Institutions
Academic and biotech projects can require different testing plans. Considerations include:
- Grant requirements increasingly mandate independent testing
- Reproducibility concerns drive verification of key reagents
- Multi-site studies need standardized peptide quality data
Peptide Suppliers
Forward-thinking suppliers use independent testing as a competitive differentiator. We've seen a shift from suppliers testing only when customers complain to proactive batch-release testing programs.
Geographic Trends
Testing demand correlates with biotech and pharmacy clusters:
- California. Biotech research communities
- Texas. Research and pharmacy communities
- Florida. Strong pharmacy testing demand
- Massachusetts. Academic and pharma research hub
- New York/New Jersey. Combined pharmaceutical corridor
All 50 states are represented in our sample intake, reflecting the nationwide reach of mail-in testing services.
